Latest Articles
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer - OncLive
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer OncLive
Published: Jan. 26, 2024, 8 a.m.
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer - Targeted Oncology
KEYNOTE-A18 Eligibility: Pembro/Chemoradiotherapy in Cervical Cancer Targeted Oncology
Published: Jan. 5, 2024, 8 a.m.
Link copied to clipboard!